Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabergoline and Pegvisomant in Active Acromegaly
2006-000344-10Phase 4Completed
- Sponsor
- The Christie
- Start
- Apr 2006
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of cabergoline and pegvisomant in acromegaly (3 arms), sponsored by The Christie. Primary endpoint: Absolute IGF-I values after each treatment condition. Started Apr 2006; status: completed.
02
Drugs
cabergolinepegvisomant
03
Conditions
acromegaly
Beyond the preview
Go deeper on 2006-000344-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000344-10.